12.09.25 -- The Future Of Biotech Outsourcing: Essential Skills For Program Managers

Explore how platform processes advance gene therapies, the impact of strong partnerships on patient access, and the future shaped by these collaborations.

Choosing the right manufacturing partner means going beyond just technical specs. Viewing the facility layouts and conditions is critical. Now is the time to familiarize yourself with remote auditing.

Discover five key factors that drive a seamless and efficient technology transfer, highlighting how a culture of technical expertise, customer focus, and operational flexibility is crucial to success in the CDMO industry.

Learn how a Stage-Gate approach to technology transfer and biomanufacturing can help to mitigate risk while shortening cycle times throughout the project lifecycle.

Adopt next-generation, physiologic T cell activation strategies to enable faster, more consistent, and scalable CAR-T manufacturing that improves expansion, persistence, and patient access.

To manufacture your rare disease therapy cost effectively, partner with an experienced CDMO from the outset. The right partner will offer development, manufacturing, quality, and regulatory expertise.

Discover analytical strategies designed to address challenges occurring during development of new molecular formats such as chain assembly, multiple-MoAs, and diverse post-translational modifications.

Achieve ADC development with an integrated approach to linker-payload design and synthesis. Learn how custom synthesis and a bioconjugation strategy accelerate candidate selection and GMP manufacturing.

This advanced cell line development technology overcomes production challenges related to the expression and scalability of complex biologics.

Scaling up viral vector production can be challenging, and ensuring consistent titers and activity requires careful optimization and technical expertise.